Serologic Testing of Donor Products
Elsevier eBooks(2013)
摘要
Each blood component must have its ABO and D antigen status tested, as a primary mechanism of preventing ABO incompatible blood transfusions and D antigen sensitization. Additionally, components must be tested for the presence of unexpected, clinically significant antibodies to prevent potential recipient hemolysis. RBC products often undergo further RBC antigen characterization in order to supply blood products for patients with alloantibodies, or patients with chronic anemia who require phenotype-matched RBC components. Most blood centers use serologic methods to perform these tests, but the use of molecular testing is growing. Serologic methods include tube testing, gel method (also known as column agglutination), or solid phase.
更多查看译文
关键词
donor products,testing
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络